<p>當接近一半的法國公司市盈率（或稱&#34;P/E&#34;）超過 17 倍時，您可能會考慮 <strong>Pernod Ricard SA</strong>（EPA:RI）作為一個具有吸引力的投資，因為它的市盈率為 11.4 倍。不過，僅僅將市盈率表面化是不明智的，因為可能有解釋説明其受限的原因。</p>
<p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前入場。</p>
<p>Pernod Ricard 最近的表現確實不錯，因為其盈利增長是積極的，而大多數其他公司則在盈利上出現了倒退。一個可能性是，市盈率低是因為投資者認為公司的盈利很快會像其他公司一樣下滑。如果不是這樣，那麼現有股東有理由對股價未來的走勢感到相當樂觀。</p>
<p>查看我們對 Pernod Ricard 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/874314-pe-multiple-vs-industry-1-dark-2/1767672708220?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1640" height="650" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/874314-pe-multiple-vs-industry-1-dark-2/1767672708220"/></p>
<p>ENXTPA:RI 市盈率與行業比較 2026 年 1 月 6 日</p>
<p>想知道分析師如何看待 Pernod Ricard 的未來與行業的對比嗎？在這種情況下，我們的 <strong>免費</strong> 報告是一個很好的起點。</p>
<h2>Pernod Ricard 有增長潛力嗎？</h2>
<p>Pernod Ricard 的市盈率對於一家僅預期有限增長的公司來説是典型的，重要的是，其表現將低於市場。</p>
<p>如果我們回顧過去一年的盈利增長，公司實現了 11% 的可觀增長。然而，這還不夠，因為最近三年期間每股收益整體下降了 16%。因此，不幸的是，我們必須承認公司在這段時間內並沒有很好地實現盈利增長。</p>
<p>展望未來，分析師預計接下來的三年每年將產生 0.03% 的增長。市場預計每年將實現 14% 的增長，因此公司面臨較弱的盈利結果。</p>
<p>根據這些信息，我們可以看到為什麼 Pernod Ricard 的市盈率低於市場。似乎大多數投資者預計未來增長有限，因此只願意以較低的價格購買該股票。</p>
<h2>我們可以從 Pernod Ricard 的市盈率中學到什麼？</h2>
<p>僅僅使用市盈率來判斷是否應該出售您的股票並不明智，但它可以作為公司未來前景的實用指南。</p>
<p>我們已經確定 Pernod Ricard 維持其低市盈率是因為其預測增長低於更廣泛的市場，正如預期的那樣。在這個階段，投資者認為盈利改善的潛力不足以證明更高的市盈率。在這種情況下，很難看到股價在不久的將來強勁上漲。</p>
<p>始終需要考慮投資風險的潛在威脅。<strong>我們已經發現 Pernod Ricard 的 2 個警告信號</strong>（至少有 1 個不應被忽視），理解這些信號應該是您投資過程的一部分。</p>
<p>您可能能夠找到比 Pernod Ricard 更好的投資。如果您想要一些可能的候選者，請查看這份 <strong>免費</strong> 的低市盈率且已證明能夠增長盈利的有趣公司名單。</p>

PRNDY

<p>Pernod Ricard SA (EPA:RI) 的市盈率為 11.4 倍，較低，這可能表明投資者對其增長預期有限。儘管最近盈利增長了 11%，但該公司在過去三年中每股收益下降了 16%。分析師預測未來三年僅有 0.03% 的年增長率，而市場預期為 14%。這表明投資者對未來盈利持謹慎態度，從而導致了低市盈率。此外，關於公司表現的警示信號也值得投資者在做出決策前考慮</p>

<p>When close to half the companies in France have price-to-earnings ratios (or &#34;P/E's&#34;) above 17x, you may consider <strong>Pernod Ricard SA</strong> (EPA:RI) as an attractive investment with its 11.4x P/E ratio. Although, it's not wise to just take the P/E at face value as there may be an explanation why it's limited.</p>
<div class="lb-trans"><p>當接近一半的法國公司市盈率（或稱&#34;P/E&#34;）超過 17 倍時，您可能會考慮 <strong>Pernod Ricard SA</strong>（EPA:RI）作為一個具有吸引力的投資，因為它的市盈率為 11.4 倍。不過，僅僅將市盈率表面化是不明智的，因為可能有解釋説明其受限的原因。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前入場。</p>
</div><p>Pernod Ricard certainly has been doing a good job lately as its earnings growth has been positive while most other companies have been seeing their earnings go backwards. One possibility is that the P/E is low because investors think the company's earnings are going to fall away like everyone else's soon. If not, then existing shareholders have reason to be quite optimistic about the future direction of the share price.</p>
<div class="lb-trans"><p>Pernod Ricard 最近的表現確實不錯，因為其盈利增長是積極的，而大多數其他公司則在盈利上出現了倒退。一個可能性是，市盈率低是因為投資者認為公司的盈利很快會像其他公司一樣下滑。如果不是這樣，那麼現有股東有理由對股價未來的走勢感到相當樂觀。</p>
</div><p>Check out our latest analysis for Pernod Ricard</p>
<div class="lb-trans"><p>查看我們對 Pernod Ricard 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/874314-pe-multiple-vs-industry-1-dark-2/1767672708220" alt="" original-src="https://images.simplywall.st/asset/chart/874314-pe-multiple-vs-industry-1-dark-2/1767672708220"/></p>
<p>ENXTPA:RI Price to Earnings Ratio vs Industry January 6th 2026</p>
<div class="lb-trans"><p>ENXTPA:RI 市盈率與行業比較 2026 年 1 月 6 日</p>
</div><p>Keen to find out how analysts think Pernod Ricard's future stacks up against the industry? In that case, our <strong>free</strong> report is a great place to start.</p>
<div class="lb-trans"><p>想知道分析師如何看待 Pernod Ricard 的未來與行業的對比嗎？在這種情況下，我們的 <strong>免費</strong> 報告是一個很好的起點。</p>
</div><h2>Is There Any Growth For Pernod Ricard?</h2>
<div class="lb-trans"><h2>Pernod Ricard 有增長潛力嗎？</h2>
</div><p>Pernod Ricard's P/E ratio would be typical for a company that's only expected to deliver limited growth, and importantly, perform worse than the market.</p>
<div class="lb-trans"><p>Pernod Ricard 的市盈率對於一家僅預期有限增長的公司來説是典型的，重要的是，其表現將低於市場。</p>
</div><p>If we review the last year of earnings growth, the company posted a worthy increase of 11%. However, this wasn't enough as the latest three year period has seen an unpleasant 16% overall drop in EPS. So unfortunately, we have to acknowledge that the company has not done a great job of growing earnings over that time.</p>
<div class="lb-trans"><p>如果我們回顧過去一年的盈利增長，公司實現了 11% 的可觀增長。然而，這還不夠，因為最近三年期間每股收益整體下降了 16%。因此，不幸的是，我們必須承認公司在這段時間內並沒有很好地實現盈利增長。</p>
</div><p>Turning to the outlook, the next three years should generate growth of 0.03% per annum as estimated by the analysts watching the company. With the market predicted to deliver 14% growth each year, the company is positioned for a weaker earnings result.</p>
<div class="lb-trans"><p>展望未來，分析師預計接下來的三年每年將產生 0.03% 的增長。市場預計每年將實現 14% 的增長，因此公司面臨較弱的盈利結果。</p>
</div><p>With this information, we can see why Pernod Ricard is trading at a P/E lower than the market. It seems most investors are expecting to see limited future growth and are only willing to pay a reduced amount for the stock.</p>
<div class="lb-trans"><p>根據這些信息，我們可以看到為什麼 Pernod Ricard 的市盈率低於市場。似乎大多數投資者預計未來增長有限，因此只願意以較低的價格購買該股票。</p>
</div><h2>What We Can Learn From Pernod Ricard's P/E?</h2>
<div class="lb-trans"><h2>我們可以從 Pernod Ricard 的市盈率中學到什麼？</h2>
</div><p>Using the price-to-earnings ratio alone to determine if you should sell your stock isn't sensible, however it can be a practical guide to the company's future prospects.</p>
<div class="lb-trans"><p>僅僅使用市盈率來判斷是否應該出售您的股票並不明智，但它可以作為公司未來前景的實用指南。</p>
</div><p>We've established that Pernod Ricard maintains its low P/E on the weakness of its forecast growth being lower than the wider market, as expected. At this stage investors feel the potential for an improvement in earnings isn't great enough to justify a higher P/E ratio. It's hard to see the share price rising strongly in the near future under these circumstances.</p>
<div class="lb-trans"><p>我們已經確定 Pernod Ricard 維持其低市盈率是因為其預測增長低於更廣泛的市場，正如預期的那樣。在這個階段，投資者認為盈利改善的潛力不足以證明更高的市盈率。在這種情況下，很難看到股價在不久的將來強勁上漲。</p>
</div><p>It's always necessary to consider the ever-present spectre of investment risk. <strong>We've identified 2 warning signs with Pernod Ricard</strong> (at least 1 which shouldn't be ignored), and understanding them should be part of your investment process.</p>
<div class="lb-trans"><p>始終需要考慮投資風險的潛在威脅。<strong>我們已經發現 Pernod Ricard 的 2 個警告信號</strong>（至少有 1 個不應被忽視），理解這些信號應該是您投資過程的一部分。</p>
</div><p>You might be able to find a better investment than Pernod Ricard. If you want a selection of possible candidates, check out this <strong>free</strong> list of interesting companies that trade on a low P/E (but have proven they can grow earnings).</p>
<div class="lb-trans"><p>您可能能夠找到比 Pernod Ricard 更好的投資。如果您想要一些可能的候選者，請查看這份 <strong>免費</strong> 的低市盈率且已證明能夠增長盈利的有趣公司名單。</p>
</div>

投資者看不到 Pernod Ricard SA (EPA:RI) 隧道盡頭的曙光